Initially, in mice that underwent subcutaneous injection of these cells, over‐expression of ZFP14 resulted in lower tumour volumes and weights, while deficiency of METTL14 produced an opposite effect which was reversed by augmenting ZFP14 (Figure 5A,B). This evidence concerns the gene METTL14 and neoplasm.